Financial Advantage’s Sanofi SNY Stock Holding History

Financial Advantage’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-28	Closed	–	–	93
2015 Q3	$0	Hold	28	–	–	﹤0.01%	113
2015 Q2	$0	Hold	28	–	–	﹤0.01%	128
2015 Q1	$0	Buy	+28	New	+$1.34K	﹤0.01%	136

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Financial Advantage's SNY Position: Q4 2015 in Review

Financial Advantage sold out of Sanofi (SNY) in Q4 2015, closing a stake of 28 shares.

Financial Advantage first reported a position in SNY in Q1 2015 and held it in 3 quarters. The position peaked at $0 in Q3 2015. 476 funds tracked by Wall St. Rank hold SNY as of Q4 2015.

Financial Advantage reported no remaining Sanofi position as of Q4 2015 after selling out during the quarter.
Financial Advantage sold 28 Sanofi shares in Q4 2015.
Financial Advantage first reported a position in Sanofi in Q1 2015 and held it in 3 quarters.
Financial Advantage's Sanofi position peaked at $0 in Q3 2015.
476 funds tracked by Wall St. Rank held Sanofi as of Q4 2015.

Based on Financial Advantage's 13F filing for Q4 2015, filed 29 Jan 2016.